Press Releases :: Journey Medical Corporation (DERM)

Nov 3, 2022

Journey Medical Corporation to Announce Third Quarter 2022 Financial Results on November 10, 2022

Oct 4, 2022

Journey Medical Corporation to Participate in Upcoming October 2022 Investor Conferences

Aug 30, 2022

Journey Medical Corporation Announces 50% Enrollment Milestone Achieved in Phase 3 Clinical Trials Evaluating DFD-29 (Minocycline Modified Release Capsules 40 mg) for the Treatment of Papulopustular Rosacea

Aug 9, 2022

Journey Medical Corporation Reports Second Quarter 2022 Financial Results and Recent Corporate Highlights

Aug 3, 2022

Journey Medical Corporation to Announce Second Quarter 2022 Financial Results on August 9, 2022

May 24, 2022

Journey Medical Corporation Announces Settlement Agreements Pertaining to QBREXZA®, AMZEEQ® and ZILXI® Patent Exclusivity

May 23, 2022

Journey Medical Corporation to Present at the B. Riley Securities 22nd Annual Institutional Investor Conference

May 10, 2022

Journey Medical Corporation Reports First Quarter 2022 Financial Results and Recent Corporate Highlights

May 3, 2022

Journey Medical Corporation to Announce First Quarter 2022 Financial Results on May 10, 2022

Apr 4, 2022

Journey Medical Corporation to Present at the Virtual Fortress Biotech R&D Summit Hosted by B. Riley Securities

rss_feed News RSS